These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20701730)
21. Methods for determining cost-benefit ratios for pharmaceuticals in Germany. von der Schulenburg J; Vauth C; Mittendorf T; Greiner W Eur J Health Econ; 2007 Sep; 8 Suppl 1():S5-31. PubMed ID: 17582539 [TBL] [Abstract][Full Text] [Related]
22. Antipodean assessment. Activities, actions, and achievements. Mitchell AS Int J Technol Assess Health Care; 2002; 18(2):203-12. PubMed ID: 12053421 [No Abstract] [Full Text] [Related]
23. Standardizing economic appraisal of health technology in the European Community. Rovira J Soc Sci Med; 1994 Jun; 38(12):1675-8. PubMed ID: 8047926 [TBL] [Abstract][Full Text] [Related]
24. Costs and benefits of radiology: a Canadian perspective. MacEwan DW; McClarty BM Acad Radiol; 1996 Apr; 3 Suppl 1():S88-91. PubMed ID: 8796525 [No Abstract] [Full Text] [Related]
25. Cost collection and analysis for health economic evaluation. Smith KA; Rudmik L Otolaryngol Head Neck Surg; 2013 Aug; 149(2):192-9. PubMed ID: 23641023 [TBL] [Abstract][Full Text] [Related]
26. Health resource allocation. A made-in-Canada description. Noseworthy T J Leg Med; 2011 Jan; 32(1):11-26. PubMed ID: 21391053 [No Abstract] [Full Text] [Related]
27. Measurement of costs. Riewpaiboon A J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S28-37. PubMed ID: 19253485 [TBL] [Abstract][Full Text] [Related]
28. Ensuring adequate payment for the use of new technology. Kaden RJ Healthc Financ Manage; 1998 Feb; 52(2):46-52. PubMed ID: 10176449 [TBL] [Abstract][Full Text] [Related]
29. The importance of subjective values to medical technology assessment and health policy. Diamond GA J Invasive Cardiol; 1993; 5(1):17-22. PubMed ID: 10148297 [No Abstract] [Full Text] [Related]
30. [Health-care costs and health technology assessment]. Lettieri E; Masella C G Ital Nefrol; 2007; 24 Suppl 40():s22-36. PubMed ID: 18034409 [TBL] [Abstract][Full Text] [Related]
31. International price comparisons for novel and follow-on drugs. Ridley DB Value Health; 2007; 10(6):510-1; discussion 512-3. PubMed ID: 17970933 [No Abstract] [Full Text] [Related]
32. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments. Ciani O; Wilcher B; van Giessen A; Taylor RS Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087 [TBL] [Abstract][Full Text] [Related]
33. High cost technology in health care: a benefit or a burden? Rutten FF; Bonsel GJ Soc Sci Med; 1992 Aug; 35(4):567-77. PubMed ID: 1519110 [TBL] [Abstract][Full Text] [Related]
34. Measurement of costs for health economic evaluation. Riewpaiboon A J Med Assoc Thai; 2014 May; 97 Suppl 5():S17-26. PubMed ID: 24964695 [TBL] [Abstract][Full Text] [Related]
35. The iatrogenic-harm cost equation and new technology. Webster CS Anaesthesia; 2005 Sep; 60(9):843-6. PubMed ID: 16115243 [No Abstract] [Full Text] [Related]
36. [Effectiveness and cost effectiveness of innovative medical techniques in public health]. Stehr H Radiologe; 1996 Apr; 36(4):279-84. PubMed ID: 8677319 [TBL] [Abstract][Full Text] [Related]
37. Medical technology assessment and the role of economic evaluation in health care. Adang EM; Ament A; Dirksen CD J Eval Clin Pract; 1996 Nov; 2(4):287-94. PubMed ID: 9238602 [TBL] [Abstract][Full Text] [Related]
38. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Gafni A; Birch S CMAJ; 1993 Mar; 148(6):913-7. PubMed ID: 8448705 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of cost effectiveness in primary health care]. Busse R; Graf von der Schulenburg JM; Drummond M Z Arztl Fortbild Qualitatssich; 1997 Aug; 91(5):447-55. PubMed ID: 9377699 [TBL] [Abstract][Full Text] [Related]